Cancers | Highly Cited Papers in 2023 in the Section “Pediatric Oncology”
As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Pediatric Oncology”, which are listed below:
1. “Synovial Sarcoma in the Extremity: Diversity of Imaging Features for Diagnosis and Prognosis”
by Eun Byul Cho, Seul Ki Lee, Jee-Young Kim and Yuri Kim
Cancers 2023, 15(19), 4860; https://doi.org/10.3390/cancers15194860
Available online: https://www.mdpi.com/2072-6694/15/19/4860
2. “Pediatric Extra-Renal Nephroblastoma (Wilms’ Tumor): A Systematic Case-Based Review”
by Akzhol Karim, Kundyz Shaikhyzada, Nazgul Abulkhanova, Akzhunis Altyn, Bakytkali Ibraimov, Dair Nurgaliyev and Dimitri Poddighe
Cancers 2023, 15(9), 2563; https://doi.org/10.3390/cancers15092563
Available online: https://www.mdpi.com/2072-6694/15/9/2563
3. “Preclinical Models of Neuroblastoma—Current Status and Perspectives”
by Ewa Krawczyk and Joanna Kitlińska
Cancers 2023, 15(13), 3314; https://doi.org/10.3390/cancers15133314
Available online: https://www.mdpi.com/2072-6694/15/13/3314
4. “Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—Updated Outcome Report”
by Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz, Moira Garraus, Cristina Larrosa, Noelia Salvador et al.
Cancers 2023, 15(9), 2535; https://doi.org/10.3390/cancers15092535
Available online: https://www.mdpi.com/2072-6694/15/9/2535
5. “Functional Alteration in the Brain Due to Tumour Invasion in Paediatric Patients: A Systematic Review”
by Nur Shaheera Aidilla Sahrizan, Hanani Abdul Manan, Hamzaini Abdul Hamid, Jafri Malin Abdullah and Noorazrul Yahya
Cancers 2023, 15(7), 2168; https://doi.org/10.3390/cancers15072168
Available online: https://www.mdpi.com/2072-6694/15/7/2168
6. “Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy”
by Holger N. Lode, Ruth Ladenstein, Sascha Troschke-Meurer, Linda Struppe, Nikolai Siebert, Maxi Zumpe, Karoline Ehlert, Stefanie Huber, Evgenia Glogova, Patrick Hundsdoerfer et al.
Cancers 2023, 15(13), 3364; https://doi.org/10.3390/cancers15133364
Available online: https://www.mdpi.com/2072-6694/15/13/3364
7. “Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia”
by Daisuke Tomizawa and Shin-Ichi Tsujimoto
Cancers 2023, 15(16), 4171; https://doi.org/10.3390/cancers15164171
Available online: https://www.mdpi.com/2072-6694/15/16/4171
8. “Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma”
by Daniela Di Carlo, Julia Chisholm, Anna Kelsey, Rita Alaggio, Gianni Bisogno, Veronique Minard-Colin, Meriel Jenney, Raquel Dávila Fajardo, Johannes H. M. Merks, Janet M. Shipley et al.
Cancers 2023, 15(6), 1644; https://doi.org/10.3390/cancers15061644
Available online: https://www.mdpi.com/2072-6694/15/6/1644
9. “Ferroptosis Inducers Kill Mesenchymal Stem Cells Affected by Neuroblastoma”
by Xiangze Li, Qi Wang, Chencheng Xu, Lei Zhang, Jiquan Zhou, Jingchun Lv, Min Xu and Dapeng Jiang
Cancers 2023, 15(4), 1301; https://doi.org/10.3390/cancers15041301
Available online: https://www.mdpi.com/2072-6694/15/4/1301
10. “Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options”
by Salman Ahmed, Waqas Alam, Michael Aschner, Rosanna Filosa, Wai San Cheang, Philippe Jeandet, Luciano Saso and Haroon Khan
Cancers 2023, 15(9), 2515; https://doi.org/10.3390/cancers15092515
Available online: https://www.mdpi.com/2072-6694/15/9/2515
11. “Dynamic Changes in Microvascular Density Can Predict Viable and Non-Viable Areas in High-Risk Neuroblastoma”
by Laura Privitera, Layla Musleh, Irene Paraboschi, Olumide Ogunlade, Olumide Ogunbiyi, J. Ciaran Hutchinson, Neil Sebire, Paul Beard and Stefano Giuliani
Cancers 2023, 15(3), 917; https://doi.org/10.3390/cancers15030917
Available online: https://www.mdpi.com/2072-6694/15/3/917
by Piotr Pawłowski, Karolina Joanna Ziętara, Justyna Michalczyk, Magdalena Fryze, Anna Buchacz, Agnieszka Zaucha-Prażmo, Joanna Zawitkowska, Anna Torres and Marzena Samardakiewicz
Cancers 2023, 15(17), 4393; https://doi.org/10.3390/cancers15174393
Available online: https://www.mdpi.com/2072-6694/15/17/4393
13. “Intracranial Germinoma—Association between Delayed Diagnosis, Altered Clinical Manifestations, and Prognosis”
by Iwona Jabłońska, Marcin Goławski, Elżbieta Nowicka, Katarzyna Drosik-Rutowicz, Anna Trybus, Rafał Tarnawski and Marcin Miszczyk
Cancers 2023, 15(10), 2789; https://doi.org/10.3390/cancers15102789
Available online: https://www.mdpi.com/2072-6694/15/10/2789
14. “DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review”
by Claudio Spinelli, Marco Ghionzoli, Linda Idrissi Sahli, Carla Guglielmo, Silvia Frascella, Silvia Romano, Carlo Ferrari, Fabrizio Gennari, Giovanni Conzo, Riccardo Morganti et al.
Cancers 2023, 15(14), 3681; https://doi.org/10.3390/cancers15143681
Available online: https://www.mdpi.com/2072-6694/15/14/3681
15. “PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma”
by Devendra Kumar, Stuti Jain, Don W. Coulter, Shantaram S. Joshi and Nagendra K. Chaturvedi
Cancers 2023, 15(24), 5855; https://doi.org/10.3390/cancers15245855
Available online: https://www.mdpi.com/2072-6694/15/24/5855
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office